{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T07:06:20Z","timestamp":1769583980317,"version":"3.49.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"48","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11,29]]},"abstract":"<jats:p>Rheumatic diseases present unique challenges in the elderly, with changes in the immune system contributing to varied clinical presentations. More individuals are now living with chronic diseases due to greater life expectancy, but there is a lack of real-world data about rheumatic diseases and comorbidities in older people. This study aimed to investigate disease types, comorbidities, treatments, and mortality in geriatric patients in comparison to non-geriatric patients at a rheumatology clinic. This retrospective observational cohort study reviewed the medical records of 2610 patients from January 2021 to January 2024 at 2 branches of a private hospital\u2019s rheumatology clinics. Demographic information and data on rheumatic diseases, noninflammatory conditions, treatments, comorbidities, and mortality were collected, and geriatric patients were compared to non-geriatric patients. Geriatric patients (n\u2005=\u2005515) had a significantly higher prevalence of rheumatoid arthritis (50.6% vs 28.8%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), polymyalgia rheumatica (11.1% vs 0.2%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), and crystal arthritis (19.6% vs 8.8%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), with more frequent geriatric-onset cases. Osteoarthritis was also more prevalent in geriatric patients (51.2% vs 11.3%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), while fibromyalgia was more common in the non-geriatric group (15.9% vs 4.1%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001). Geriatric patients experienced higher rates of comorbidities, including hypertension (72.4% vs 17.8%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), diabetes (33.6% vs 12.1%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), and osteoporosis (64.9% vs 35.4%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001). These patients used more corticosteroids (74.5% vs 44%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), and conventional synthetic disease-modifying antirheumatic drugs (62.4% vs 49.4%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001) but fewer biological disease-modifying antirheumatic drugs (9.2% vs 23.1%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001). Mortality rates were significantly higher in geriatric patients (6% vs 0.3%), with cancer (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.001), ischemic heart disease (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.04), heart failure (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.01), chronic kidney disease (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.02), and interstitial lung disease (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.01) being associated with increased mortality. Geriatric rheumatology should receive greater focus in future research to help address the anticipated increases in demand and to develop tailored management strategies for elderly patients with rheumatic diseases and comorbidities.<\/jats:p>","DOI":"10.1097\/md.0000000000040753","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T21:00:09Z","timestamp":1732914009000},"page":"e40753","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Comprehensive analysis of rheumatic diseases, comorbidities, and mortality in geriatric population: Real-world data of 515 patients in a single rheumatology clinic"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5539-8755","authenticated-orcid":false,"given":"Senem","family":"Tekeoglu","sequence":"first","affiliation":[{"name":"Department of Medicine, Rheumatology, School of Medicine, Halic University, Istanbul, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"12 Pt 2","key":"R1-20250503","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1301\/nr.2007.dec.S173-S176","article-title":"Inflammaging as a major characteristic of old people: can it be prevented or cured?","volume":"65","author":"Franceschi","year":"2007","journal-title":"Nutr Rev"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(16)31679-8","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the global burden of disease study 2015.","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1183\/13993003.00829-2015","article-title":"Connective tissue diseases, multimorbidity and the ageing lung.","volume":"47","author":"Spagnolo","year":"2016","journal-title":"Eur Respir J"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/ggi.13742","article-title":"Era of geriatric medical challenges: multimorbidity among older patients.","volume":"19","author":"Kuzuya","year":"2019","journal-title":"Geriatr Gerontol Int"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrrheum.2013.212","article-title":"Multimorbidity and rheumatic conditions-enhancing the concept of comorbidity.","volume":"10","author":"Radner","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"R7-20250503","first-page":"234","article-title":"Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.","volume":"33","author":"Bathon","year":"2006","journal-title":"J Rheumatol"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaad.2009.09.040","article-title":"Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis.","volume":"63","author":"Menter","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/rheumatology\/key165","article-title":"Management of inflammatory rheumatic conditions in the elderly.","volume":"58","author":"Lahaye","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"vi5","DOI":"10.1093\/rheumatology\/kes279","article-title":"ACR\/EULAR 2010 rheumatoid arthritis classification criteria.","volume":"51","author":"Kay","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The assessment of SpondyloArthritis international society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study.","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League against Rheumatism\/American College of rheumatology classification criteria for systemic lupus erythematosus.","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts.","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","article-title":"2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative.","volume":"71","author":"Dasgupta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative [published correction appears in Ann Rheum Dis. 2016 Feb;75(2):473].","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R17-20250503","first-page":"1078","article-title":"International study group for Beh\u00e7et\u2019s disease.","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1136\/ard-2022-223480","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis [published correction appears in Ann Rheum Dis. 2023 Feb;82(2):e52].","volume":"81","author":"Ponte","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1136\/ard-2022-223482","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for Takayasu arteritis.","volume":"81","author":"Grayson","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/annrheumdis-2021-221795","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis.","volume":"81","author":"Robson","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.1780331101","article-title":"The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand.","volume":"33","author":"Altman","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780290816","article-title":"Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.","volume":"29","author":"Altman","year":"1986","journal-title":"Arthritis Rheum"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/art.1780340502","article-title":"The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip.","volume":"34","author":"Altman","year":"1991","journal-title":"Arthritis Rheum"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity.","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"R26-20250503","first-page":"1477","article-title":"Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis.","volume":"24","author":"Wolfe","year":"1997","journal-title":"J Rheumatol"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"769329","DOI":"10.3389\/fmed.2022.769329","article-title":"Glomerular filtration in the aging population.","volume":"9","author":"Noronha","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. modification of diet in renal disease study group.","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: a review.","volume":"322","author":"Chen","year":"2019","journal-title":"JAMA"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0889-857X(05)70154-X","article-title":"Elderly-onset rheumatoid arthritis.","volume":"26","author":"Yazici","year":"2000","journal-title":"Rheum Dis Clin North Am"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1002\/art.22193","article-title":"Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials.","volume":"54","author":"Zink","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/rheumatology\/kel144","article-title":"Are rheumatologists\u2019 treatment decisions influenced by patients\u2019 age?","volume":"45","author":"Fraenkel","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/ard.2005.051144","article-title":"Do patients with older-onset rheumatoid arthritis receive less aggressive treatment?","volume":"65","author":"Tutuncu","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s40266-019-00705-5","article-title":"Pathogenesis, diagnosis and management of polymyalgia rheumatica.","volume":"36","author":"Camellino","year":"2019","journal-title":"Drugs Aging"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00391-017-1197-3","article-title":"Crystal arthritides - gout and calcium pyrophosphate arthritis: part 1: epidemiology and pathophysiology. Kristallarthritiden \u2013 Gicht und Kalziumpyrophosphat-Arthritis: Teil 1: Epidemiologie und Pathophysiologie.","volume":"51","author":"Schlee","year":"2018","journal-title":"Z Gerontol Geriatr"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2147\/OARRR.S282606","article-title":"Understanding and managing corticosteroid-induced osteoporosis.","volume":"13","author":"Kobza","year":"2021","journal-title":"Open Access Rheumatol"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1532-5415.1993.tb01892.x","article-title":"The problems of pain and its detection among geriatric nursing home residents.","volume":"41","author":"Sengstaken","year":"1993","journal-title":"J Am Geriatr Soc"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","article-title":"Osteoarthritis.","volume":"386","author":"Glyn-Jones","year":"2015","journal-title":"Lancet"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780380104","article-title":"The prevalence and characteristics of fibromyalgia in the general population.","volume":"38","author":"Wolfe","year":"1995","journal-title":"Arthritis Rheum"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/annrheumdis-2013-204223","article-title":"Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).","volume":"73","author":"Dougados","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R44-20250503","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/annrheumdis-2015-208174","article-title":"Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study.","volume":"75","author":"Molt\u00f3","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R45-20250503","article-title":"Cardiovascular diseases;","year":"2024"},{"key":"R46-20250503","article-title":"Cancer;","year":"2024"},{"key":"R47-20250503","article-title":"Death and causes of death statistisc","year":"2022"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040753","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:01:28Z","timestamp":1746316888000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":43,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040753","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,29]]}}}